1,000
Participants
Start Date
October 8, 2024
Primary Completion Date
January 20, 2025
Study Completion Date
January 20, 2025
mRNA-1273.712
Intramuscular (IM) injection.
Placebo
Sodium chloride for IM injection.
Velocity Clinical Research, Syracuse, East Syracuse
Velocity Clinical Research, Washington DC, Washington D.C.
Velocity Clinical Research, Durham, Durham
Velocity Clinical Research, Anderson, Anderson
Velocity Clinical Research, Savannah, Savannah
Velocity Clinical Research, Gulfport, Gulfport
Velocity Clinical Research, Cleveland, Beachwood
Velocity Clinical Research, Cincinnati, Blue Ash, Blue Ash
Velocity Clinical Research, Cincinnati, Cincinnati
Velocity Clinical Research, Valparaiso, Valparaiso
Velocity Clinical Research, Omaha, Omaha
Velocity Clinical Research, Lincoln, Lincoln
Velocity Clinical Research, Grand Island, Grand Island
Velocity Clinical Research, New Orleans, New Orleans
Velocity Clinical Research, Covington, Covington
Velocity Clinical Research, Lafayette, Lafayette
Velocity Clinical Research, Abilene, Abilene
Velocity Clinical Research, Banning, San Bernardino
Velocity Clinical Research, Boise, Meridian
Velocity Clinical Research, Salt Lake City, West Jordan
Velocity Clinical Research, Phoenix, Phoenix
Velocity Clinical Research, Albuquerque, Albuquerque
Velocity Clinical Research, Huntington Park, Huntington Park
Velocity Clinical Research, San Diego, La Mesa
ModernaTX, Inc.
INDUSTRY